E-LIB Suche - Ergebnisse für: El Roz, A.

1

The emergence of SARS-COV-2 variant(s) and its impact on th..:

Noureddine, F.Y. ; Chakkour, M. ; El Roz, A....
Clinica Chimica Acta. 558 (2024) - p. 119368 , 2024

Link: https://doi.org/10.1016/..

2

234: MMP2 as a molecular biomarker of proficient tumor–stro..:

Baldoli, E. ; Caputo, T. ; Bertolini, G....
European Journal of Cancer. 50 (2014) - p. S54 , 2014

Link: https://doi.org/10.1016/..

3

Mir-660 is downregulated in lung cancer patients and its re..:

Fortunato, O ; Boeri, M ; Moro, M...
Cell Death & Disease. 5 (2014) 12 - p. e1564-e1564 , 2014

Link: https://doi.org/10.1038/..

4

Adipose tissue displays trophic properties on normal lung c..:

Andriani, F. ; Facchinetti, F. ; Furia, S....
Journal of Cellular Physiology. 228 (2013) 6 - p. 1166-1173 , 2013

Link: https://doi.org/10.1002/..

5

The anti-proliferative and pro-apoptotic effects of the tra..:

El Roz, A. ; Bard, J.M. ; Huvelin, J.M..
Prostaglandins, Leukotrienes and Essential Fatty Acids. 88 (2013) 4 - p. 265-272 , 2013

Link: https://doi.org/10.1016/..

6

362 Lung Derived Fibroblasts Influence Extracellular Matrix..:

Andriani, F. ; Caputo, T. ; Facchinetti, F....
European Journal of Cancer. 48 (2012) - p. S88 , 2012

Link: https://doi.org/10.1016/..

7

372 The Subset of CD133+/CXCR4+/EpCAM- Cancer Initiating Ce..:

Bertolini, G. ; Moro, M. ; Tortoreto, M....
European Journal of Cancer. 48 (2012) - p. S90 , 2012

Link: https://doi.org/10.1016/..

8

P150 L'effet antiprolifératif de l'isomère trans9, trans11 ..:

El Roz, A. ; Huvelin, J.-M. ; Bard, J.-M..
Nutrition Clinique et Métabolisme. 25 (2011) - p. S125 , 2011

Link: https://doi.org/10.1016/..

9

Effect of inducible FHIT and p53 expression in the Calu-1 l..:

Cavazzoni, A. ; Galetti, M. ; Fumarola, C....
Cancer Letters. 246 (2007) 1-2 - p. 69-81 , 2007

Link: https://doi.org/10.1016/..

10

The effect of plasticizers on thermoplastic starch composit..:

ROZ, A ; CARVALHO, A ; GANDINI, A.
Carbohydrate Polymers. 63 (2006) 3 - p. 417-424 , 2006

Link: https://doi.org/10.1016/..

11

Is a prophylactic treatment by erythropoietin relevent to r..:

Liet, Jean-Michel ; Paranon, Soizic ; Baraton, Louis..
Pediatric Critical Care Medicine. 7 (2006) 6 - p. 618 , 2006

Link: https://doi.org/10.1097/..

12

Is a prophylactic treatment by erythropoietin relevant to r..:

Liet, Jean-Michel ; Paranon, Soizic ; Baraton, Louis..
Pediatric Critical Care Medicine. 7 (2006) 6 - p. 541-544 , 2006

Link: https://doi.org/10.1097/..

13

Is a prophylactic treatment by erythropoietin relevent to r..:

Liet, Jean-Michel ; Paranon, Soizic ; Baraton, Louis..
Pediatric Critical Care Medicine. 7 (2006) 6 - p. 615 , 2006

Link: https://doi.org/10.1097/..

14

Is a prophylactic treatment by erythropoietin relevent to r..:

Liet, Jean-Michel ; Paranon, Soizic ; Baraton, Louis..
Pediatric Critical Care Medicine. 7 (2006) 6 - p. 614 , 2006

Link: https://doi.org/10.1097/..

15

Is a prophylactic treatment by erythropoietin relevent to r..:

Liet, Jean-Michel ; Paranon, Soizic ; Baraton, Louis..
Pediatric Critical Care Medicine. 7 (2006) 6 - p. 613 , 2006

Link: https://doi.org/10.1097/..